dc.contributor.author |
Ker, James A.
|
|
dc.date.accessioned |
2016-09-02T07:57:20Z |
|
dc.date.available |
2016-09-02T07:57:20Z |
|
dc.date.issued |
2016-07 |
|
dc.description.abstract |
There is enough documented evidence of the role of low-density-lipoprotein cholesterol (LDL-C)
in the pathogenesis of atherosclerotic cardiovascular disease (CVD). |
en_ZA |
dc.description.department |
Internal Medicine |
en_ZA |
dc.description.librarian |
am2016 |
en_ZA |
dc.description.uri |
http://www.specialistforum.co.za |
en_ZA |
dc.identifier.citation |
Ker, J 2016, 'LDL-cholesterol reduction vs LDL target level : which is more important?', The Specialist Forum, vol. 16, no. 6, pp. 38. |
en_ZA |
dc.identifier.issn |
2218-8282 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/56588 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
New Media Publishing |
en_ZA |
dc.rights |
© The Specialist Forum |
en_ZA |
dc.subject |
CVD events |
en_ZA |
dc.subject |
Treatment |
en_ZA |
dc.subject |
Low-density-lipoprotein cholesterol (LDL-C) |
en_ZA |
dc.subject |
Cardiovascular disease (CVD) |
en_ZA |
dc.subject |
Cardiovascular risk |
en_ZA |
dc.title |
LDL-cholesterol reduction vs LDL target level : which is more important? |
en_ZA |
dc.type |
Article |
en_ZA |